The present invention relates to the use of at least one antibody and/or one inhibitorfor inhibiting factor XII and preventing the formation and/or the stabilizationof threedimensional thrombi. It also relates to a pharmaceutical formulationand the use of factor XII as an anti-thrombotic target.